Cigna Group $CI Shares Sold by M&T Bank Corp

Key Points

• M&T Bank Corp decreased its stake by 9.6% in Cigna during Q4, selling 4,344 shares and leaving a 41,085‑share holding valued at $11.309 million per its SEC filing.
• Cigna beat quarterly expectations, reporting $7.79 EPS vs. $7.60 expected and $68.52 billion in revenue vs. $66.29 billion, and set FY2026 guidance around 30.35 EPS (analysts forecast ~30.4).
• Cigna announced a quarterly dividend of $1.56 (annualized $6.24, ~2.3% yield), with an ex‑dividend date of June 4 and payment on June 18.

M&T Bank Corp decreased its stake in Cigna Group (NYSE:CI - Free Report) by 9.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,085 shares of the health services provider's stock after selling 4,344 shares during the quarter. M&T Bank Corp's holdings in Cigna Group were worth $11,309,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CI. Vanguard Group Inc. grew its holdings in shares of Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider's stock worth $7,203,754,000 after buying an additional 414,834 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock worth $3,249,113,000 after buying an additional 903,334 shares in the last quarter. Dodge & Cox grew its holdings in shares of Cigna Group by 4.0% during the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider's stock worth $2,682,231,000 after buying an additional 354,615 shares in the last quarter. Sanders Capital LLC grew its holdings in shares of Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider's stock worth $2,256,469,000 after buying an additional 35,150 shares in the last quarter. Finally, Capital Research Global Investors grew its holdings in shares of Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider's stock worth $916,434,000 after buying an additional 1,855,897 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

Cigna Group Trading Down 1.3%

CI opened at $275.73 on Wednesday. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The stock has a market capitalization of $72.94 billion, a PE ratio of 11.69, a P/E/G ratio of 0.98 and a beta of 0.30. The business's 50 day moving average price is $274.24 and its 200 day moving average price is $276.50. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts' consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to analysts' expectations of $66.29 billion. During the same period in the prior year, the firm posted $6.74 earnings per share. The firm's quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts expect that Cigna Group will post 30.4 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group's dividend payout ratio is currently 26.45%.

Insider Buying and Selling

In related news, insider Everett Neville sold 1,719 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Nicole S. Jones sold 2,307 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on CI shares. Sanford C. Bernstein upped their target price on shares of Cigna Group from $358.00 to $371.00 and gave the stock an "outperform" rating in a report on Tuesday. Robert W. Baird set a $337.00 price objective on Cigna Group in a research note on Friday. Raymond James Financial set a $340.00 price objective on Cigna Group in a research note on Friday. Guggenheim boosted their price objective on Cigna Group from $334.00 to $338.00 and gave the stock a "buy" rating in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Cigna Group from $301.00 to $304.00 and gave the stock a "buy" rating in a research note on Tuesday, February 10th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $338.35.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.